ArticleJournal of veterinary internal medicine2016
Treatment of MRI-Diagnosed Trigeminal Peripheral Nerve Sheath Tumors by Stereotactic Radiotherapy in Dogs.
Article in Journal of veterinary internal medicine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed, 40 citations in OpenAlex.
- Clinical Findings and Outcome in 30 Dogs with Presumptive or Confirmed Nerve Sheath Tumors.Veterinary sciences · 2024Article
- Case report: Presumptive subcutaneous malignant peripheral nerve sheath tumor with intracranial invasion and osteolysis in the posterior fossa of a dog.Frontiers in veterinary science · 2022Article
- CyberKnife stereotactic radiotherapy for treatment of primary intracranial tumors in dogs.Journal of veterinary internal medicine · 2021Article
- A rare case of malignant vagus nerve sheath tumor presenting with multiple cranial nerve dysfunction in a dog.The Canadian veterinary journal = La revue veterinaire canadienne · 2020Article
- Low Field MRI Measurements of the Normal Canine Trigeminal Nerve.Frontiers in veterinary science · 2020Article
- Central nervous system metastasis of an intradural malignant peripheral nerve sheath tumor in a dog.Open veterinary journal · 2019Article
- Clinical findings and outcome of dogs with unilateral masticatory muscle atrophy.Journal of veterinary internal medicine · 2019Article
- Imaging in Non-neurologic Oncologic Treatment Planning of the Head and Neck.Frontiers in veterinary science · 2019Review
- Comparative evaluation of a novel, moderately hypofractionated radiation protocol in 56 dogs with symptomatic intracranial neoplasia.Journal of veterinary internal medicine · 2018Article
- A survey of stereotactic radiation therapy in veterinary medicine.Veterinary radiology & ultrasound : the official journal of the American College of Veterinary Radiology and the International Veterinary Radiology Association · 2018Article
- Consensus recommendations on standardized magnetic resonance imaging protocols for multicenter canine brain tumor clinical trials.Veterinary radiology & ultrasound : the official journal of the American College of Veterinary Radiology and the International Veterinary Radiology Association · 2018Article
- Volumetric Modulated Arc (Radio) Therapy in Pets Treatment: The "La Cittadina Fondazione" Experience.Cancers · 2018Review
- Relationship between magnetic resonance imaging findings and histological grade in spinal peripheral nerve sheath tumors in dogs.Journal of veterinary internal medicineArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 2 institutions in 1 country.
Funding
Abstract
backgroundStereotactic radiotherapy (SRT) is an emerging technique for treating tumors in animals.
objectivesTo assess the outcome of dogs with suspected intracranial trigeminal nerve peripheral nerve sheath tumors (PNST) treated with SRT. ANIMALS: Eight dogs with presumptive PNST.
methodsThis was a retrospective study of dogs identified by searching UC Davis Veterinary Medical Teaching Hospital medical records for dogs treated with SRT for a presumed PNST. Presumptive diagnosis was based on magnetic resonance imaging. SRT was delivered in 3 dose fractions of 8 Gray (Gy) on consecutive days or every other day to a total dose of 24 Gy.
resultsMedian disease-specific survival was 745 days (range: 99-1375 days, n = 6). No signs of acute adverse effects of radiation treatment were recorded. Late radiation effects versus tumor progression could not be confirmed histopathologically because of few animals undergoing necropsy. CONCLUSIONS AND CLINICAL IMPORTANCE: This study provides preliminary evidence that dogs with PNST benefit from SRT in terms of long-term survival. The treatment appears to be well tolerated and requires fewer anesthetic events for animals compared to full-course radiation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.